STOCK TITAN

Cellebrite Di Ltd Stock Price, News & Analysis

CLBT Nasdaq

Welcome to our dedicated page for Cellebrite Di news (Ticker: CLBT), a resource for investors and traders seeking the latest updates and insights on Cellebrite Di stock.

Cellebrite DI Ltd (NASDAQ: CLBT) provides authoritative digital intelligence solutions to law enforcement and enterprises worldwide. This news hub offers investors and professionals a centralized resource for tracking corporate developments, technological advancements, and strategic initiatives shaping the digital forensics sector.

Access timely updates including earnings reports, product launches, partnership announcements, and regulatory filings. Our curated collection ensures stakeholders stay informed about critical developments affecting investigative technology markets, cybersecurity trends, and Cellebrite’s position as a leader in legally sanctioned data analysis solutions.

Key updates cover innovations in mobile device forensics, cloud data extraction tools, and enterprise-grade investigative platforms. Regular monitoring of this page provides insights into Cellebrite’s subscription revenue growth, global expansion efforts, and responses to evolving data privacy regulations.

Bookmark this page for structured access to CLBT’s official communications and third-party analysis. Combine technical understanding of digital intelligence markets with strategic business insights through our maintained news archive.

Rhea-AI Summary

Cellebrite (NASDAQ: CLBT) announced Tim Tebow as the keynote speaker for their inaugural Case-to-Closure (C2C) User Summit scheduled for March 31-April 3, 2025, in Washington, D.C. The summit will gather digital investigation leaders to discuss industry trends and best practices. Tebow will address his foundation's global fight against human trafficking, aligning with Cellebrite's Operation Find Them All initiative. The event will feature over three dozen speakers covering various digital investigative topics, including notable case studies and technological developments. Attendees will have opportunities for networking, professional training, and knowledge expansion across different levels of the investigative process.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.32%
Tags
none
-
Rhea-AI Summary

Cellebrite (Nasdaq: CLBT), a leader in Digital Investigative solutions, has patented its Remote Mobile Collection technology. This innovation, available in Cellebrite's SaaS platforms Endpoint Mobile Now and Endpoint Inspector, enables corporate investigators to perform immediate, targeted remote data collection from mobile devices.

Key benefits include:

  • Time and cost savings for businesses
  • Faster device access and analysis
  • Convenience for device owners, who can retain their devices during collection
  • Ability to collect data from multiple devices simultaneously
  • Improved data accessibility with results available within hours

According to Cellebrite's 2024 Industry Trends Survey, 83% of respondents rely on multiple tools for data collection. This patented technology aims to streamline this process, particularly in today's hybrid work environment.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.54%
Tags
none
-
Rhea-AI Summary

Cellebrite DI (Nasdaq: CLBT) has announced the results of its completed redemption of all outstanding warrants. Key points include:

- 99.4% of outstanding Public Warrants were exercised, with 4,645 exercised for cash and 19,878,580 exercised cashlessly.

- 116,224 unexercised Public Warrants were redeemed for $11,622.40.

- All 9,666,667 Private Placement Warrants were exercised cashlessly.

- Public Warrants have stopped trading on Nasdaq and been delisted.

- The redemption does not affect the trading of Cellebrite's Ordinary Shares (CLBT).

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.1%
Tags
none
Rhea-AI Summary

Cellebrite (Nasdaq: CLBT) has announced the availability of Pathfinder in the Cloud with Amazon Web Services (AWS), enhancing its investigative analytics solution for law enforcement agencies. This cloud-based offering allows customers to access Pathfinder through Amazon's secure Virtual Private Cloud (VPC), providing flexible deployment options and scalable resources.

Key features of Pathfinder include AI-driven data analysis, slang identification, explicit image categorization, Optical Character Recognition (OCR), and Automated Translation Services. The cloud deployment eliminates the need for physical servers and secure rooms, offering cost-effective scaling, rapid resource commissioning, and high availability.

This update aims to accelerate digital evidence analysis, reduce investigation time, and improve case resolution efficiency for law enforcement agencies of all sizes.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.06%
Tags
none
-
Rhea-AI Summary

Cellebrite DI (Nasdaq: CLBT) has announced the 'Redemption Fair Market Value' for its previously announced warrant redemption. The company will redeem all outstanding warrants at $0.10 per warrant on September 16, 2024. Warrant holders can exercise their warrants for cash at $11.50 per Ordinary Share or on a 'cashless basis' before the redemption date. Based on the Redemption Fair Market Value of $16.72, holders exercising warrants on a cashless basis will receive 0.342 Ordinary Shares per Warrant.

The company has obtained a ruling from Israeli Tax Authorities exempting certain qualified holders from potential tax withholding upon share issuance. Unexercised warrants after the redemption date will be void. The last trading day for Public Warrants on Nasdaq will be September 13, 2024.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.99%
Tags
none
-
Rhea-AI Summary

Cellebrite (NASDAQ: CLBT) announced its second-quarter 2024 financial results with revenue of $95.7 million, marking a 25% year-over-year increase due to a 27% growth in subscription revenue. The company reported an Annual Recurring Revenue (ARR) of $345.9 million, up 26% YoY, and an adjusted EBITDA of $21.6 million with a 22.6% margin.

GAAP net loss was $23.8 million, while non-GAAP net income was $22.9 million. The company also raised its 2024 outlook for revenue and adjusted EBITDA, forecasting full-year revenue between $390 million and $398 million and adjusted EBITDA between $90 million and $95 million.

Cellebrite expanded its operations by forming Cellebrite Federal Solutions and acquiring Cyber Technology Services, Inc. Additionally, it partnered with Relativity to enhance mobile device collection and processing solutions. The company also announced the redemption of 30 million outstanding warrants and the issuance of 5 million Price Adjustment Shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.32%
Tags
Rhea-AI Summary

Cellebrite DI (Nasdaq: CLBT) has announced the redemption of all outstanding warrants to purchase ordinary shares at $0.10 per warrant, effective September 16, 2024. This includes public and private placement warrants. Warrantholders can choose to exercise their warrants for cash at $11.50 per share or surrender them on a 'cashless basis' before the redemption date. The company has obtained a ruling from Israeli Tax Authorities exempting certain qualified holders from potential tax withholding upon share issuance. Unexercised warrants after the redemption date will be void. The last trading day for public warrants on Nasdaq is expected to be September 13, 2024.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.32%
Tags
none
-
Rhea-AI Summary

Cellebrite (NASDAQ: CLBT), a leader in digital investigative solutions, has appointed Troy K. Richardson to its Board of Directors. Richardson, a tech veteran with over 30 years of experience, brings significant operational and sales expertise from leading technology companies. He currently serves on the Unisys Board and previously held senior roles at PTC, DXC, Oracle, SAP, HP, Novell, and IBM. With Richardson's addition, Cellebrite's board now consists of 10 directors.

Thomas Hogan, Executive Chairman, expressed enthusiasm about Richardson's appointment, highlighting his deep knowledge of the software industry and broad leadership experience. Richardson stated his excitement to join Cellebrite, praising the company's leadership position in digital investigation and intelligence gathering, as well as its culture of innovation and social responsibility.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.01%
Tags
management
-
Rhea-AI Summary

Cellebrite (NASDAQ: CLBT), a global leader in Digital Investigative solutions, has appointed Sigalit Shavit as its first-ever Chief Information Officer (CIO), effective August 1, 2024. With over 30 years of experience, Shavit joins Cellebrite's Leadership Team, reporting directly to CEO Yossi Carmil. Her role will be important in scaling the company's innovation and customer support capabilities.

Shavit's appointment comes at a time when Cellebrite's technical innovation is vital in combating sophisticated criminals and managing growing digital evidence. She will focus on supporting business needs, addressing cyber threats, leveraging AI, and accelerating innovation. Recognized as one of the Top 25 Women Leaders in Cybersecurity, Shavit brings valuable experience from her previous roles at FedEx Express, ECI Telecom, CyberArk, and KTrust.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.26%
Tags
management
Rhea-AI Summary

Relativity and Cellebrite (Nasdaq: CLBT) have announced a strategic partnership to develop innovative solutions for mobile device collection, processing, and review in the legal technology sector. The collaboration includes:

1. A RelativityOne and Cellebrite Remote Mobile Collection and Conversion integration.

2. Cellebrite becoming the only mobile collection provider natively integrated into RelativityOne Collect.

3. Automatic conversion of Cellebrite's UFD file format to Relativity Short Message Format (RSMF) upon collection.

An Advanced Access program for the integration will launch in the U.S. this month, with general availability expected in fall 2024. This partnership aims to improve efficiency, accessibility, and usability of mobile evidence in legal data use cases.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.29%
Tags
partnership

FAQ

What is the current stock price of Cellebrite Di (CLBT)?

The current stock price of Cellebrite Di (CLBT) is $15.78 as of June 13, 2025.

What is the market cap of Cellebrite Di (CLBT)?

The market cap of Cellebrite Di (CLBT) is approximately 4.0B.
Cellebrite Di Ltd

Nasdaq:CLBT

CLBT Rankings

CLBT Stock Data

4.03B
116.51M
49.99%
51.45%
0.5%
Software - Infrastructure
Technology
Link
Israel
Petah Tikva